I. Chau and D. Cunningham, Adjuvant therapy in colon cancer: current status and future directions, Cancer Treatment Reviews, vol.28, issue.5, pp.223-236, 2002.
DOI : 10.1016/S0305-7372(02)00047-6

C. De-braud, F. Wilson, A. Morvan, and . Bonetti, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J Clin Oncol, pp.18-2938, 2000.

T. Jandik, J. Iveson, M. Carmichael, G. Alakl, L. Gruia et al., Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, Lancet, pp.355-1041, 2000.

R. M. Mader, M. Muller, and G. G. Steger, Resistance to 5-Fluorouracil, General Pharmacology: The Vascular System, vol.31, issue.5, pp.31-661, 1998.
DOI : 10.1016/S0306-3623(98)00191-8

H. Jakesz, G. G. Rainer, and . Steger, Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro, Biochem Pharmacol, vol.54, pp.1233-1242, 1997.

D. B. Longley, D. P. Harkin, and P. G. Johnston, 5-Fluorouracil: mechanisms of action and clinical strategies, Nature Reviews Cancer, vol.3, issue.5, pp.330-338, 2003.
DOI : 10.1038/nrc1074

G. J. Peters, H. H. Backus, S. Freemantle, B. Van-triest, G. Codacci-pisanelli et al., Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1587, issue.2-3, pp.1587-194, 2002.
DOI : 10.1016/S0925-4439(02)00082-0

M. Takahashi, C. Maesawa, K. Saito, T. Takechi, and M. Fukushima, Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR, Jpn J Cancer Res, pp.93-1342, 2002.

. Hirayama, Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidinebased chemotherapy for metastatic colorectal cancer, Clin Cancer Res, vol.9, pp.786-791, 2003.

J. Lenz, C. G. Leichman, L. Leichman, R. B. Diasio, and P. V. Danenberg, Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase, Clin Cancer Res, vol.6, pp.1322-1327, 2000.

. Milano, Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients, J Clin Oncol, vol.15, pp.2604-2610, 1997.

H. Francois, M. Richelme, C. Mousseau, D. Letoublon, H. Pezet et al., Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data, Clin Cancer Res, vol.3, pp.553-557, 1997.

B. Kovacs, L. Budai, A. Hullan, and . Jeney, Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors, Oncology, pp.62-167, 2002.

]. A. Morel, A. M. O-'carroll, M. J. Brownstein, and S. J. Lolait, Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors, Regulatory Peptides, vol.45, issue.1-2, pp.356-523, 1992.
DOI : 10.1016/0167-0115(93)90182-8

R. H. Deprez, A. C. Fijnvandraat, J. M. Ruijter, and A. F. Moorman, Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions, Anal Biochem, pp.307-63, 2002.

X. J. Tso, T. H. Sun, K. S. Kao, R. Reece, and . Wu, Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene, Nucleic Acids Research, vol.13, issue.7, pp.13-2485, 1985.
DOI : 10.1093/nar/13.7.2485

J. Winer, C. K. Jung, I. Shackel, and P. M. Williams, Development and validation of realtime quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro, Anal Biochem, pp.270-311, 1999.

T. Kitajima, M. Takechi, and . Fukushima, Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens, Cancer Sci, pp.94-633, 2003.

B. Tzankov, P. Bousquet, T. L. Morel, and . Bricon, Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler system, Clin Chim Acta, pp.306-133, 2001.

K. Klein, M. J. Behan, R. O-'connell, J. W. Levitt, M. T. Kugler et al., Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer, J Clin Oncol, pp.20-1735, 2002.

M. Machiavelli, C. J. De-lena, P. G. Allegra, and . Johnston, Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients, Br J Cancer, pp.82-560, 2000.

A. B. Van-kuilenburg, Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil, European Journal of Cancer, vol.40, issue.7, pp.40-939, 2004.
DOI : 10.1016/j.ejca.2003.12.004

]. Y. Konishi, R. Kanamaru, C. Ishioka, A. Ishikawa, H. Shibata et al., The changes in the levels of dihydrofolate reductase mRNA and its gene dosage in 5-fluorouracil-resistant L1210 cells., The Tohoku Journal of Experimental Medicine, vol.161, issue.1, pp.161-194, 1990.
DOI : 10.1620/tjem.161.33

F. S. Wang, C. Aschele, A. Sobrero, Y. M. Chang, and J. R. Bertino, Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance, Cancer Res, pp.53-3677, 1993.

. Gustavsson, Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients, Clin Cancer Res, vol.9, pp.6012-6019, 2003.

J. Koruth and . Cassidy, Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours, Br J Cancer, vol.77, pp.461-465, 1998.

M. Ikeguchi, Y. Hirooka, M. Makino, and N. Kaibara, Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine, Oncology Reports, vol.8, pp.621-625, 2001.
DOI : 10.3892/or.8.3.621

H. Elsaleh, D. Joseph, G. F. Rieu, N. Zeps, N. Spry et al., Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer, The Lancet, vol.355, issue.9217, pp.355-1745, 2000.
DOI : 10.1016/S0140-6736(00)02261-3

M. Yoshida, T. Kimoto, and . Tsunoda, Gender differences in the dihydropyrimidine dehydrogenase expression of colorectal cancers, Cancer Lett, vol.188, pp.231-236, 2002.

T. Yasutake, Y. Nagayasu, and . Tagawa, Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone, Cancer Lett, pp.204-97, 2004.

S. W. Choi and J. B. Mason, Folate status: effects on pathways of colorectal carcinogenesis

]. B. Akoglu, D. Faust, V. Milovic, and J. Stein, Folate and chemoprevention of colorectal cancer: is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells?, Nutrition, vol.17, issue.7-8, pp.17-652, 2001.
DOI : 10.1016/S0899-9007(01)00594-9

]. R. Jaszewski, A. Khan, F. H. Sarkar, O. Kucuk, M. Tobi et al., Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines, Am J Physiol, pp.277-1142, 1999.

F. M. Gaynon, J. R. Uckun, R. Bertino, and . Gorlick, Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study, J Pediatr Hematol Oncol, pp.25-688, 2003.

J. Boyer, E. G. Mclean, S. Aroori, P. Wilson, A. Mcculla et al., Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan, Clinical Cancer Research, vol.10, issue.6, pp.10-2158, 2004.
DOI : 10.1158/1078-0432.CCR-03-0362

]. K. Isshi, T. Sakuyama, T. Gen, Y. Nakamura, T. Kuroda et al., Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU, International Journal of Clinical Oncology, vol.7, issue.6, pp.335-342, 2002.
DOI : 10.1007/s101470200051